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endometriosis and chronic 
pelvic pain have similar impact 
on women, but time to diagnosis 
is decreasing: an Australian survey
Mike Armour1,2*, Justin Sinclair1, cecilia H. M. ng3, Mikayla S. Hyman4, Kenny Lawson2, 
caroline A. Smith1,2 & Jason Abbott3
Chronic pelvic pain (CPP) affects a significant number of women worldwide. Internationally, people 
with endometriosis report significant negative impact across many areas of their life. We aimed to 
use an online survey using the EndoCost tool to determine if there was any difference in the impact 
of CPP in those with vs. those without a confirmed diagnosis of endometriosis, and if there was any 
change in diagnostic delay since the introduction of clinical guidelines in 2005. 409 responses were 
received; 340 with a diagnosis of endometriosis and 69 with no diagnosis. People with CPP, regardless 
of diagnosis, reported moderate to severe dysmenorrhea and non-cyclical pelvic pain. Dyspareunia 
was also common. Significant negative impact was reported for social, academic, and sexual/romantic 
relationships in both cohorts. In the endometriosis cohort there was a mean diagnostic delay of eight 
years, however there was a reduction in both the diagnostic delay (p < 0.001) and number of doctors 
seen before diagnosis (p < 0.001) in those presenting more recently. Both endometriosis and CPP have 
significant negative impact. Whilst there is a decrease in the time to diagnosis, there is an urgent need 
for improved treatment options and support for women with the disease once the diagnosis is made.
Chronic pain in women and girls has been identified as a top five health concern by Australian  women1 and is 
identified by a government report as an Australian National Women’s Health  Priority2. There are a variety of 
causes for chronic pelvic pain (CPP) including endometriosis, adenomyosis, chronic infection, vulvodynia irri-
table bowel syndrome or bladder pain syndrome. Endometriosis is the most common cause of  CPP3, accounting 
for 24–40% of all CPP  diagnoses4,5 and has a prevalence rate of around 11% in  Australia6. Some people have no 
demonstrated pathology despite detailed surgical investigation or imaging, leading to a diagnosis of Chronic 
Pelvic Pain Syndrome (CPPS).
It has been repeatedly demonstrated internationally that endometriosis has a long diagnostic  delay7, impacts 
people’s health and  wellbeing8, including social  activities9, mental and emotional  health10,11, work/finances9,12, 
and sexual  relationships13; and those with endometriosis report physical quality of life similar to that of cancer 
 patients9. Most research has focused on endometriosis rather than non-endometriosis CPP however previous 
studies have shown that it is the pelvic pain caused by endometriosis, rather than just the presence of endometrial 
lesions, that impacts quality of  life14. Therefore it is plausible that people with non-endometriosis related CPP 
experience similar issues but possibly with less severe  impact15. However there is a paucity of research in this area.
The aim of this survey was to determine in an Australian population, with endometriosis or non-endo-
metriosis related CPP, the process of diagnosis, the prevalence of different CPP symptoms, and to explore the 
management and impact on people’s social, sexual/romantic, work, and academic lives.
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Methods
Questionnaire. The World Endometriosis Research Foundation (WERF) EndoCost tool consists of vali-
dated prospective hospital questionnaires and both retrospective and prospective patient  questionnaires16. 
Our study used the 99 item retrospective patient questionnaire, modified to Australian income and ethnicity 
parameters as per the Australian Bureau of  Statistics17. The survey was hosted on SurveyMonkey (www.surve 
ymonk ey.com), with an estimated 30–45 min completion time. The cost of illness burden has been previously 
 published12, with this paper reporting on items contributing to the WERF Global Study on Women’s  Health9. It 
focuses on diagnosis, education, work and social wellbeing as well as recent (3 month) prevalence of other pelvic 
pain symptoms such as dysmenorrhea and dyspareunia.
Recruitment. Following ethics approval by the Western Sydney University Human Research Ethics Com-
mittee, (approval number H12019), the survey link was distributed via the social media platforms (Facebook, 
Twitter and Instagram) of Endometriosis Australia, EndoActive and Pelvic Pain Foundation of Australia from 
February 2017 to April 2017, for a total of 8 weeks. The total combined reach of these organizations on social 
media was just over 35,000 followers at the time of survey distribution. Each organization made two social media 
posts regarding the survey 3–5 weeks apart. Data collection was closed once there had been no new responses 
for five days. Informed consent was obtained from all participants. Both the participant information sheet and 
the survey introduction outlined that completion of the survey implied consent. All research complied with the 
relevant guidelines and regulations outlined in the National Statement on Ethical Conduct in Human Research 
(2018)18.
Study population. People were eligible to participate in the survey if they were aged 18–45, currently living 
in Australia and either had a surgically confirmed diagnosis of endometriosis, or if they had CPP from any cause. 
CPP was defined as pain in the pelvis for at least six months that caused the person to seek medical attention. 
Those with CPP either had a laparoscopy that did not show evidence of endometriosis or had not undergone a 
laparoscopy at the time of survey. This study was designed to measure prevalence of symptoms and assess their 
impact rather than test a hypothesis, therefore no sample size calculation was performed.
Analyses. Data were analysed using SPSS v26 (IBM Corporation, Chigago Ill.). Descriptive statistics were 
presented as means and standard deviations (for normally distributed data), medians and interquartile ranges 
(for non-normally distributed data), or number and percentages (for categorical data). Inferential statistics 
for between-group comparisons were performed using a one-way ANOVA, chi-square test or Fishers Exact as 
appropriate. Correlations between categorical and continuous variables were analysed using Spearman’s rank 
order correlation, and correlations between two continuous variables were analysed using Pearson’s Correlation. 
Statistical significance was set at p < 0.05. Missing data were reported and not replaced.
To explore the potential effect of the introduction of the first publication of the European Society of Human 
Reproduction and Embryology (ESHRE) diagnostic guidelines in  200519, the 2013 World Endometriosis Society 
(WES) diagnostic guidelines and updated ESHRE guidelines in  201320,21 we planned to group the analysis on 
diagnostic delay and number of doctors seen prior to diagnosis into three groups based on the timing of their 
first presentation to a doctor; presentation prior to 2005, presentation between 2005 and 2012, and presentation 
from 2013 onwards.
Results
409 valid responses were received. 340 of these people had endometriosis (83%) and 69 (17%) had CPP without a 
current diagnosis of endometriosis. Table 1 outlines the demographic characteristics of survey participants. The 
mean age of respondents identifying as being affected by endometriosis was 30.6 (± 7) and CPP was 33.7 (± 16.3) 
years. The majority of respondents earned between AUD$510–$1500 per week, with a little more than half of 
people across both groups held either university or post-secondary qualifications. In people with endometriosis, 
33.7% reported stage IV disease at their most recent laparoscopy.
Symptoms and diagnosis. Table 2 outlines the diagnostic data and symptoms at onset for both cohorts. A 
Pearson’s correlation found a statistically significant, strong negative correlation between the year when medical 
attention was first sought and the number of years taken to get a diagnosis of endometriosis, r = − 0.71, p < 0.001. 
We compared the delay between when medical attention was first sought and found a significant difference in 
delay for the person who first sought medical attention prior to 2005 (9.9 ± 6.6 years), between 2005 and 2012 
(4.8 ± 2.6 years) and from 2013 (1.5 ± 0.7 years) onwards (p < 0.001). A Spearman’s correlation was performed 
and found there was a statistically significant negative correlation between the year when medical attention 
was first sought and the number of doctors seen to get a diagnosis in people with endometriosis,  rs = − 0.305, 
p < 0.001. Similar to the reduction in delay, the number of doctors seen before diagnosis was also reduced signifi-
cantly after the introduction of the first ESHRE guideline (p < 0.001).
There was a moderate negative correlation between the year symptoms first appeared and the delay in seeking 
medical attention, r = − 0.39, p < 0.001.
People experiencing dysmenorrhea with every period in the previous three months were comparable between 
the endometriosis (85.9%) and CPP (87.0%) cohorts, and dyspareunia was common in both groups, with over 
two thirds of respondents with endometriosis (69.1%) and CPP (66.7%) reporting experiencing pelvic pain either 
with or in the 24 h after intercourse (Table 3).
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Social, educational and work impact. Substantial negative impact was reported across both cohorts in 
education, employment and social domains (Table 4).
Personal relationships were similarly affected between cohorts, with more than half of respondents indicat-
ing problems with their sexual or romantic partners. For those who said pelvic pain impacted their personal 
relationships around one in six people in either group indicated that this had caused the breakdown of their 
relationship. The most commonly reported impact for people with endometriosis (35.9%) was that it affected 
their friendships. At least one in five people in each cohort indicated that they found it difficult to look after 
children, and almost a third indicated it caused issues with their family.
Non-cyclical pelvic pain. Supplementary Table S1 compares the prevalence, severity and management of 
non-cyclical pelvic pain between cohorts.
Table 1.  Demographics.
Endometriosis (n = 340) Chronic Pelvic Pain (n = 69)
Mean (SD) Mean (SD)
Age (years) 30.6 (7.0) 33.7 (16.3)
Ethnicity, n (%)
Caucasian 312 (91.8%) 64 (92.8%)
Asian 5 (1.5%) 2 (2.9%)
Aboriginal/TSI 5 (1.5%) 1 (1.4%)
Polynesian 0 (0%) 0 (0%)
Maori 0 (0%) 0 (0%)
Other 17 (5%) 2 (2.8%)
Blank 1 (0.3%) 0 (0%)
Relationship status, n (%)
Single 69 (20.3%) 14 (20.3%)
Married/Defacto 211 (62.1%) 50 (72.5%)
In a relationship but not living with partner 49 (14.4%) 4 (5.8)
Divorced/Separated 9 (2.6%) 0 (0%)
Widowed 0 (0%) 1 (1.4%)
Blank 2 (0.6%) 0 (0%)
Occupation, n (%)
Self-employed 23 (6.8%) 4 (5.8%)
Employed 236 (69.4%) 47 (68.1%)
Going to school or University 70 (20.6%) 15 (21.7%)
Home duties/ caring for children and family 43 (12.6%) 10 (14.5%)
Doing voluntary work 18 (5.3%) 2 (2.9%)
Unable to work due to pelvic pain symptoms 23 (6.8%) 7 (10.1%)
Unable to work for other reasons 5 (1.5%) 2 (2.9%)
Level of education, n (%)
Primary School 0 (0%) 0 (0%)
Lower secondary 24 (7%) 2 (2.9%)
Upper secondary 47 (13.8%) 6 (8.7%)
Post-secondary (TAFE) 91 (26.8%) 22 (31.9%)
University 123 (36.2%) 25 (36.2%)
Post graduate 55 (16.2%) 14 (20.3%)
Blank 0 (0%) 0 (0%)
Currently have children, n (%)
Yes 97 (28.5%) 23 (33.3%)
No 242 (71.2%) 46 (66.7%)
Blank 1 (> 1%) 0 (0%)
Endometriosis stage at most recent laparoscopy, n (%)
Stage 1 14 (4.1%)
Stage 2 51 (15%)
Stage 3 75 (22.1%)
Stage 4 115 (33.7%)
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Discussion
Data from this study demonstrates that people with CPP, irrespective of diagnosis, commonly report moderate 
to severe pelvic pain symptoms, consistent with recent research on  endometriosis22. People with endometriosis 
frequently report symptom onset (most commonly dysmenorrhea and pelvic pain) in their late teens and overall 
report an eight year diagnostic delay from symptom onset. Nearly three years of this delay is due to the person not 
presenting to their medical care provider and the remaining 5 years between initial presentation to a doctor and 
a surgical diagnosis of endometriosis. This is similar to the delay reported in other  studies9,23 and may, at least be 
in part, be due to a normalization of the severe dysmenorrhea that is frequently reported in young people with 
pelvic  pain24–26. It may also represent commonly held beliefs that even moderate or greater severity menstrual 
or pelvic pain is a normal part of ‘becoming a woman’ or ‘something you need to put up with’ as documented in 
qualitative  studies23,27,28. However, our findings indicate that this delay in presentation to a medical professional is 
reducing over time, with those reporting their symptoms that have started more recently showing a shorter time 
delay in seeking medical attention. This may be due to an increased awareness of the symptoms of endometriosis 
and encouragement to seek medical assistance for these through the efforts of advocacy organizations and the 
recent increased media coverage of endometriosis including events such as Endometriosis Awareness Month. 
A variety of educational programs, both in person and online, designed to improve awareness of menstruation 
and endometriosis have also been developed for Australia and  elsewhere29–33. Most of these resources have been 
implemented in 2019 and beyond, therefore, given the timing of our survey, it is too soon to see whether these 
programs may contribute to any further reduction in diagnostic delay.
Similarly, the clinician seeing the person with CPP for the first time may normalize those  symptoms23 or 
provide other diagnoses such as irritable bowel syndrome or sexually transmitted  infections28,34, which can lead 
to frustration for the patient and further delay in appropriate management that targets their symptoms. Since 
the introduction of the ESHRE guideline on endometriosis in 2005, there appears to be a significant reduction 
in both the number of doctors seen before diagnosis and the time between seeking medical help and a diagnosis 
of endometriosis. It is unclear at this time if an earlier diagnosis of endometriosis will improve pain and fertil-
ity outcomes. However, earlier identification of abnormal menstrual symptoms in early education  programs29 
may allow for an earlier intervention that could change the course of disease and, at least, improve the quality of 
life of those affected if appropriately managed. This goal is identified in the Australian National Action Plan for 
 Endometriosis35 and needs further investigation in future research studies.
Pain and the associated symptom of fatigue is commonly seen in people with  endometriosis22,36 and are 
significant contributors to both the work and education-related absenteeism and presenteeism seen in our 
 respondents28. Fatigue is a common symptom in people with endometriosis and other types of pelvic pain with 
39–43% of respondents reporting that symptom at the onset and all clinicians should ask about this symptom 
when taking a history of a person presenting with pelvic pain. The fatigue experienced may be  debilitating37 and 
there is a strong correlation between pain severity and  fatigue38, almost certainly explaining why chronic fatigue 




Chronic pelvic pain (n = 69)
Mean (SD) P value
Age when symptoms first appeared 18 (6) 21.9 (8.6)  < 0.001*
Time between symptom onset and first doctors visit (years) 2.9 (4.4) 1.8 (3.4) 0.07
Time between doctors visit and diagnosis of endometriosis (years) 4.9 (5.7) N/A N/A
Number of Doctors seen before diagnosis of endometriosis 5 (4) N/A N/A
Number of doctors seen by year of first presentation
Prior to 2005 7.3 (7.0) N/A N/A
Between 2005 and 2012 4.3 (3.2) N/A N/A
2013 onwards 3.9 (2.6) N/A N/A
Time between year of first presentation and diagnosis
First sought medical attention before 2005 9.9 (6.6) N/A N/A
First sought medical attention between 2005–2012 4.8 (2.6) N/A N/A
First sought medical attention after 2013 1.5 (0.7) N/A N/A
Symptoms at onset, n (%)
Severe Dysmenorrhea 260 (89.4%) 57 (82.6%)
0.66
Deep Dyspareunia 84 (32.3%) 27 (39.1%)
Pelvic Pain 229 (78.7%) 51 (73.9%)
Ovulation pain 136 (46.7%) 29 (42%)
Cyclical or peri-menstrual symptoms (e.g. bowel or bladder associated) with 
or without abnormal bleeding 111 (38.1%) 33(47.8%)
Infertility 22 (7.6%) 6 (8.7%)
Chronic Fatigue 113 (38.8%) 25 (36.2%)
Blank 25 (7.4%) 0 (0%)
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syndrome is much more common in people with endometriosis than the general  population38. Educational 
absenteeism in our survey led to giving up study for 25–50% of people. This is notable since academic achieve-
ment declines with any  absenteeism39,40. Absenteeism also increases social isolation and decreases engagement 
with peers. The  community41 and the consequential cessation of education may substantially limit long-term 
opportunities for people with endometriosis and CPP.
Previous international  surveys8,9 and qualitative  research23,28 have highlighted the impact of endometriosis 
on social activities and marital/sexual relationships. We also demonstrated that personal relationships, whether 
friendships or those of a romantic/sexual nature, were negatively impacted by endometriosis and CPP. Reasons 
for this may include the fatigue experienced reducing social  interactions36,38 and increased anxiety of expe-
riencing heavy menstrual bleeding, nausea, gastrointestinal and bladder  symptoms28 in public places when 
interacting with friends, family or others. Similar to previous  work13, romantic and sexual relationships were 
commonly affected in both cohorts, with pain as a direct contributor, but fatigue, nausea, depression, and other 
co-morbidities also, often, contributing to relationship strain and potential  breakdown42.
Compared to those with endometriosis people with CPP had symptom onset later, in their early 20 s, but 
with similar presenting symptoms. Previous work also identified a substantial number of people who report 
Table 3.  Description of menstrual symptoms and sexual intercourse. *Represents significance (p < 0.001).
Endometriosis (n = 340) Chronic Pelvic Pain (n = 69) P value
Pelvic pain with periods in last 3 months, n (%)
Yes 292 (85.9%) 60 (87.0%)
0.92No 46 (13.5%) 7 (10.1%)
Blank 2 (0.6%) 2 (2.9%)
Frequency of pain, n (%)
0.42
Occasionally 9 (3.1%) 2 (3.3%)
Often 27 (9.2%) 9 (15.0%)
Always 247 (84.6%) 48 (80.0%)
Blank 9 (3.1%) 1 (1.7%)
Severity of period pain (average), median (IQR) 7 (6–8) 7 (6–8) 0.57
Severity of period pain (worse), median (IQR) 8 (8–10) 8.5 (8–9) 0.91
Use of painkillers, n (%)
 < 0.001*Uses prescription 181 (62.0%) 16 (23.2%)
Uses OTC 57 (19.5%) 46 (66.7%)
Affected daily living, n (%)
0.85
Never 16 (5.5%) 5 (8.3%)
Occasionally 81 (27.7%) 15 (25.0%)
Often 100 (34.2%) 21 (35.0%)
Always 85 (29.1%) 18 (30%)
Blank 7 (2.4%) 1 (1.7%)
Pelvic pain with intercourse, n (%)
1.00
Yes 235 (69.1%) 46 (66.7%)
No 30 (8.8%) 19 (27.5%)
Blank/Other 55 (16.2%) 4 (5.8%)
Frequency of pelvic pain after intercourse, n (%)
0.22
Occasionally 37 (15.7%) 12 (26.1%)
Often 38 (16.2%) 6 (13.0%)
Usually 74 (31.5%) 15 (32.6%)
Always 86 (36.6%) 11 (23.9%)
Blank 0 (0%) 2 (4.3%)
Interrupt intercourse, n (%)
0.94
Yes 193 (82.1%) 38 (82.6%)
No 42 (17.9%) 6 (13.0%)
Blank 0 (0%) 2 (4.3%)
Avoid intercourse, n (%)
0.89
Yes 209 (88.9%) 39 (84.8%)
No 26 (11.1%) 5 (10.9%)
Blank 0 (0%) 2 (4.3%)
Pain during intercourse, median (IQR) 6 (4–7) 5 (4–8) 0.91
Pain 24 h after intercourse, median (IQR) 6 (6–6) 6 (4–7) 0.74
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CPP symptoms but have not been given any  diagnosis43,44. Of course, pelvic pain may later be diagnosed as 
 endometriosis22 but most importantly, our work confirms that both diagnosed and non-diagnosed CPP causes 
substantive negative impact on work, education, sexual relationships, family and friendships. It is therefore neces-
sary to identify and have a treatment plan for pelvic pain symptoms, regardless of the current or future diagnosis.
There are a number of strengths of this study. Whilst this is the first Australian study for endometriosis and 
there exist similar estimates from other  countries8,45,46, there are no previous data on the impact of CPP. The 
use of the WERF EndoCost tool also allows comparison between datasets generated between different centers. 
However, there are limitations of this study that must be acknowledged. The overall sample size is small, which 
may reflect the in-depth nature of the questionnaires, which required up to 45 min to complete. Respondents 
were asked to answer the endometriosis section only if they had a histologically confirmed surgical diagnosis 
although confirmatory evidence of that was not possible. We recognize that people designated to the CPP cohort 
may have undiagnosed endometriosis, which is an eventual diagnosis in 33–75%37,38 of this group. Importantly, 
our study demonstrates similar negative impacts across many domains irrespective of diagnosis. We did not 
collect data on geographical location of respondents, so it is possible that our sample did not represent potential 
variations in the access to appropriately specialised health care professionals, work, or educational opportunities. 
Respondents were predominantly Caucasian, and therefore caution must be heeded in extrapolating these find-
ings to other culturally and linguistically diverse groups. Given the timing of the survey in early 2017, there may 
Table 4.  Social, educational and work impact.
Endometriosis (n = 340) Chronic Pelvic Pain (n = 69)
Have you ever lost time to education due to your chronic pelvic pain? n (%)
Yes 197 (57.9%) 29 (42.0%)
No 57 (16.8%) 26 (37.7%)
Blank, n (%) 86 (25.3%) 14 (20.3%)
How did it effect your education (please select all that apply)? n (%)
Gave up studies 47 (23.9%) 13 (44.8%)
Changed studies 17 (8.6%) 4 (13.8%)
Delayed exams 114 (57.9%) 15 (51.7%)
Other 64 (32.5%) 3 (10.3%)
Blank 6 (3.0%) 3 (10.3%)
Average number of days lost per month when you were studying due to your pelvic pain, mean (SD) 6.5 (7.1) 5.4 (5.0)
Has chronic pelvic pain affected your job? n (%)
Yes 199 (58.5%) 35 (50.7%)
No 52 (15.3%) 18 (26.1%)
Blank 89 (26.2%) 16 (23.2%)
If yes, how did it affect your job (please select all that apply)? n (%)
Lost job 30 (15.1%) 3 (8.6%)
Changed job 25 (12.6%) 2 (5.7%)
Reduced hours 108 (54.3%) 22 (62.9%)
Other 100 (50.3%) 17 (48.6%)
Blank 2 (1.0%) 1 (2.9%)
Average number of days per month you had to take off work due to your chronic pelvic pain? median (IQR) 4 (2–8) 3.5 (2–6.75)
Have you been scared to tell your employer that you have chronic pelvic pain because you feared that it might affect your prospects? n (%)
Yes 171 (50.3%) 36 (52.2%)
No 67 (19.7%) 13 (18.8%)
Blank 102 (30.0%) 20 (29.0%)
Has chronic pelvic pain ever affected your personal relationships in a negative way? n (%)
Yes 202 (59.4%) 43 (62.3%)
No 43 (12.6%) 9 (13.0%)
Blank 95 (27.9%) 17 (24.6%)
If yes, how did it affect your personal relationships? (please select all that apply), n (%)
Caused significant problems with partner 120 (59.4%) 27 (62.8%)
Created problems with family 54 (26.7%) 13 (30.2%)
Caused a relationship to split 31 (15.3%) 6 (14.0%)
Difficult to look after children 45 (22.3%) 11 (25.6%)
Affected friendships 122 (60.4%) 20 (46.5%)
Other 70 (34.7%) 14 (32.6%)
Blank 5 (2.5%) 1 (2.3%)
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be a ceiling effect with respect to diagnostic delay for the cohort that presented to their health care professional 
after 2013. However, the reported diagnostic delay observed between 2005 and 2012 is unlikely to be affected by 
any ceiling effect. Finally, our recruitment was almost solely via advisory and support groups on social media, 
and people recruited via this method are likely to have more severe symptoms than those recruited in other set-
tings such as tertiary  care47. So it is possible that our respondents may be biased towards a more severe impact 
of their symptoms on their lives and may not represent the population of people with endometriosis as a whole.
conclusion
People with CPP, regardless of a diagnosis of endometriosis, experience significant negative impact across a range 
of domains including education, work, social, and romantic/sexual relationships. It is likely that it is the severity 
of the pelvic pain symptoms, rather than the underlying cause which is the key driver for these diverse negative 
impacts, and may have long lasting consequences if not appropriately recognised and managed through access 
to adequate health care resources. Our findings suggest that there has been a significant decrease in diagnostic 
delay for people with endometriosis over time, possibly due to improved guidelines and advocacy. However, the 
diagnostic delay still exists and still carries a significant burden to those suffering CPP. Widespread, evidence 
based educational programs, recognising the symptom profile of CPP, for both the public and medical provid-
ers, are urgently needed to help reduce this delay and implement and provide access to the most appropriate 
management plan for these people.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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